Unichem Laboratories is currently trading at Rs. 252.30, up by 6.85 points or 2.79% from its previous closing of Rs. 245.45 on the BSE.
The scrip opened at Rs. 248.00 and has touched a high and low of Rs. 255.25 and Rs. 247.90 respectively. So far 3177 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 374.90 on 21-May-2021 and a 52 week low of Rs. 197.50 on 22-Nov-2021.
Last one week high and low of the scrip stood at Rs. 262.05 and Rs. 243.60 respectively. The current market cap of the company is Rs. 1773.87 crore.
The promoters holding in the company stood at 50.93%, while Institutions and Non-Institutions held 10.75% and 38.32% respectively.
Unichem Laboratories has received ANDA approval for its Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Bystolic (nebivolol) Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg, of Allergan Sales, LLC.
Nebivolol Tablets are indicated for the treatment of hypertension. The product will be commercialized from Unichem’s Ghaziabad Plant.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |